Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis
Péter Döme, Péter Kunovszki, Péter Takács, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245510-e0245510
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Treatment-Resistant Depression: Approaches to Treatment
Karan Kverno, Emma Mangano
Journal of Psychosocial Nursing and Mental Health Services (2021) Vol. 59, Iss. 9, pp. 7-11
Closed Access | Times Cited: 88
Novel drug developmental strategies for treatment‐resistant depression
Éva Borbély, Mária Simon, Eberhard Fuchs, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 6, pp. 1146-1186
Open Access | Times Cited: 69
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials
Róbert György Vida, Eszter Sághy, Richárd Bella, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Trends in research on novel antidepressant treatments
Agnieszka Zelek-Molik, Ewa Litwa
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Examining the needs, outcomes and current treatment pathways of 2461 people with treatment-resistant depression: mixed-methods study
Kiranpreet Gill, Danielle Hett, Max Carlish, et al.
The British Journal of Psychiatry (2025), pp. 1-8
Closed Access | Times Cited: 1
Treatment-Resistant Depression in Poland—Epidemiology and Treatment
Piotr Gałecki, Jerzy Samochowiec, Magdalena Mikułowska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 480-480
Open Access | Times Cited: 25
Overview of treatment-resistant depression
Cheng‐Ta Li
Progress in brain research (2023), pp. 1-23
Closed Access | Times Cited: 15
Care pathways, prescribing practices and treatment outcomes in major depressive disorder and treatment-resistant depression: retrospective, population-based cohort study
Sofia Pappa, Moulesh Shah, Sophie Young, et al.
BJPsych Open (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Treatment-resistant depression and risk of autoimmune diseases: evidence from a population-based cohort and nested case-control study
Vivien Kin Yi Chan, Hao Luo, Sandra S. M. Chan, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Cardiovascular Risk Predicts White Matter Hyperintensities, Brain Atrophy and Treatment Resistance in Major Depressive Disorder: Role of Genetic Liability
Marco Paolini, Melania Maccario, V. Saredi, et al.
Acta Psychiatrica Scandinavica (2025)
Open Access
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data
Elise Koch, Sophie Smart, Guðmundur Einarsson, et al.
The Lancet Psychiatry (2025)
Closed Access
The complexity of treatment-resistant depression: A data-driven approach
Felicitas Rost, Thomas Booker, Aneliya Gonsard, et al.
Journal of Affective Disorders (2024) Vol. 358, pp. 292-301
Open Access | Times Cited: 3
Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study
Markku Lähteenvuo, Heidi Taipale, Antti Tanskanen, et al.
Journal of Affective Disorders (2022) Vol. 308, pp. 236-242
Open Access | Times Cited: 14
The prevalence and economic burden of treatment-resistant depression in Thailand
Jirada Prasartpornsirichoke, Nuttorn Pityaratstian, Chayanit Poolvoralaks, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
The burden associated with, and management of, difficult-to-treat depression in patients under specialist psychiatric care in the United Kingdom
Tiago Costa, Bayar Menzat, Tomas Engelthaler, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 5, pp. 545-556
Open Access | Times Cited: 13
Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder
Antal Zemplényi, J. Józwiak-Hagymásy, Sandor Kovács, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Mortality in patients with major depressive disorder: A nationwide population-based cohort study with 11-year follow-up
István Bitter, György Szekeres, Qian Cai, et al.
European Psychiatry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 2
Clinical and Biological Factors Are Associated with Treatment-Resistant Depression
Massimiliano Buoli, Enrico Capuzzi, Alice Caldiroli, et al.
Behavioral Sciences (2022) Vol. 12, Iss. 2, pp. 34-34
Open Access | Times Cited: 10
The Individual and Societal Burden of Treatment-Resistant Depression
Kimberlyn Maravet Baig-Ward, Manish K. Jha, Madhukar H. Trivedi
Psychiatric Clinics of North America (2023) Vol. 46, Iss. 2, pp. 211-226
Open Access | Times Cited: 4
Multiomics and blood-based biomarkers of electroconvulsive therapy in severe and treatment-resistant depression: study protocol of the DetECT study
Iven-Alex von Mücke-Heim, Julius C. Pape, Norma C. Grandi, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 274, Iss. 3, pp. 673-684
Open Access | Times Cited: 3
Study to determine the epidemiology of treatment-resistant depression among the Saudi Arabian population: A cross-sectional study
Abdullah S. Alshehri, Abdullah Algarni, Hussein Ahmed M. Almahdi, et al.
Journal of Education and Health Promotion (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Personalized Approach in the Management of Difficult-to-Treat and Treatment-Resistant Depression With Second-Generation Antipsychotics: A Delphi Statement
Hansal Bhachech, Kamal Nath, Roop Sidana, et al.
Cureus (2024)
Open Access
Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray
Ludovic Samalin, Lila Mékaoui, Pierre de Maricourt, et al.
International Journal of Psychiatry in Clinical Practice (2024), pp. 1-11
Closed Access
Langzeitverläufe der depressiven Erkrankung
Rebecca Paetow, Thomas Frodl
Der Nervenarzt (2024)
Open Access
Plasminogen Activator Inhibitor‐1 in the Pathophysiology of Late Life Depression
Lucie Métivier, Denis Vivien, R. Goy, et al.
International Journal of Geriatric Psychiatry (2024) Vol. 39, Iss. 11
Closed Access
Page 1 - Next Page

Scroll to top